No me los he leído. Pero se supone que son esos.
I. Galve-Roperh, C. Sánchez, M.L. Cortés, T. Gómez del Pulgar, M. Izquierdo, M. Guzmán
Antitumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
Nat.Med. 6, 313-319 (2000)
C. Sánchez, M.L. de Ceballos, T. Gómez del Pulgar, D. Rueda, C. Corbacho, G. Velasco, I. Galve-Roperh, J.W. Huffman, S. Ramón y Cajal, M. Guzmán
Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor
Cancer Res. 61, 5784-5789 (2001)
M.M. Caffarel, D. Sarrió, J. Palacios, M. Guzmán, C. Sánchez
D9-Tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation
Cancer Res. 66, 6615-6621 (2006)
M.M. Caffarel, G. Moreno-Bueno, C. Cerutti, J. Palacios, M. Guzmán, F. Mechta-Grigoriou, C. Sánchez
JunD is involved in D9-tetrahydrocannabinol antiproliferative effect on human breast cancer cells
Oncogene 27, 5033-5044 (2008)
M.M. Caffarel, C. Andradas, E. Mira, C. Cerutti, J.M. Flores, G. Moreno-Bueno, I. García-Real, J. Palacios, S. Mañes, M. Guzmán, C.
Sánchez
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Mol. Cancer 9, 196 (2010)
C. Andradas, M.M. Caffarel, E. Pérez-Gómez, M. Salazar, M. Lorente, G. Velasco, M. Guzmán, C. Sánchez
The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK
Oncogene (aceptado, 2010)